Landmark: Sanofi announces to reduce price of TB drug Rifapentine by 70 percent Medical Dialogues Bureau1 Nov 2019 3:29 PM ISTScale-up of affordable Rifapentine stands to benefit over a million people in India alone, where more people suffer from TB than anywhere else in the...
Mylan moves application with DCGI to launch new TB drug Pretomanid in India Medical Dialogues Bureau16 Oct 2019 4:10 PM IST"We have submitted the new drug application to the office of DCGI. We are in an advanced stage of discussion and are working with the office of...
Technical Committee recommends CDSCO to approve import, marketing of Sanofi TB drug with clinical trial waiver Farhat Nasim28 May 2019 4:21 PM ISTNew Delhi: Apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has been recommended by the Techincal Committee to granted...
